EDNRB

endothelin receptor type B, the group of Endothelin receptors

Basic information

Region (hg38): 13:77895481-77975529

Previous symbols: [ "HSCR2", "HSCR" ]

Links

ENSG00000136160NCBI:1910OMIM:131244HGNC:3180Uniprot:P24530AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Waardenburg syndrome type 4A (Strong), mode of inheritance: AD
  • Waardenburg syndrome type 4A (Strong), mode of inheritance: AR
  • ABCD syndrome (Definitive), mode of inheritance: AD
  • Waardenburg syndrome type 2 (Supportive), mode of inheritance: AD
  • Waardenburg-Shah syndrome (Supportive), mode of inheritance: AD
  • Waardenburg syndrome type 4A (Moderate), mode of inheritance: Semidominant
  • Hirschsprung disease, susceptibility to, 2 (Limited), mode of inheritance: Unknown
  • Waardenburg syndrome type 4A (Strong), mode of inheritance: AR
  • Waardenburg syndrome type 4A (Limited), mode of inheritance: AD
  • Waardenburg syndrome type 4A (Moderate), mode of inheritance: AR
  • Waardenburg syndrome type 4A (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Waardenburg syndrome type 4A; ABCD syndrome; Hirschsprung disease, susceptibility to, 2AD/ARAudiologic/Otolaryngologic; GastrointestinalEarly recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Recognition of potential GI manifestations (eg, Hirschsprung disease) may allow prompt treatmentAudiologic/Otolaryngologic; Dermatologic; Gastrointestinal; Ophthalmologic7264803; 8001158; 8634719; 7778600; 10528251; 11484199; 11891690; 19764031

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the EDNRB gene.

  • not provided (10 variants)
  • Waardenburg syndrome type 4A (4 variants)
  • Rare genetic deafness (1 variants)
  • ABCD syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the EDNRB gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
31
clinvar
2
clinvar
36
missense
1
clinvar
2
clinvar
103
clinvar
4
clinvar
110
nonsense
6
clinvar
3
clinvar
2
clinvar
11
start loss
0
frameshift
4
clinvar
6
clinvar
3
clinvar
13
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
3
clinvar
7
clinvar
10
splice region
2
2
4
non coding
48
clinvar
24
clinvar
12
clinvar
84
Total 14 18 160 59 14

Highest pathogenic variant AF is 0.00000659

Variants in EDNRB

This is a list of pathogenic ClinVar variants found in the EDNRB region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
13-77895535-A-G Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)884085
13-77895620-G-A Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)884086
13-77895737-A-G Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)884087
13-77895748-C-T Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)884088
13-77895774-T-G Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)312442
13-77895845-A-G Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)312443
13-77895891-A-G Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)312444
13-77895908-T-G Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 15, 2018)880798
13-77895942-C-A Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)312445
13-77895981-T-C Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)312446
13-77896033-G-C Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)312447
13-77896035-G-A Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)312448
13-77896136-A-C Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)312449
13-77896145-T-C Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)312450
13-77896153-G-A Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)882190
13-77896159-A-G Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)882191
13-77896294-C-T Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)312451
13-77896340-A-C Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)312452
13-77896356-T-C Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)882192
13-77896416-T-C Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)882193
13-77896433-G-A not specified • Hirschsprung disease, susceptibility to, 2 Benign/Likely benign (Mar 04, 2019)226627
13-77896538-A-G Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 12, 2018)312453
13-77896568-G-T not specified Uncertain significance (May 21, 2015)228659
13-77896600-A-G Hirschsprung disease, susceptibility to, 2 Uncertain significance (Jan 13, 2018)882439
13-77896654-T-C Hirschsprung disease, susceptibility to, 2 Benign/Likely benign (Jul 05, 2018)312454

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
EDNRBprotein_codingprotein_codingENST00000377211 824288
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.009240.990125588081255960.0000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.182362930.8050.00001453437
Missense in Polyphen3168.1290.45502857
Synonymous0.7291061160.9140.000006071072
Loss of Function3.07824.30.3290.00000119286

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009070.0000906
Ashkenazi Jewish0.00009950.0000992
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00004430.0000440
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Non-specific receptor for endothelin 1, 2, and 3. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. {ECO:0000269|PubMed:7536888}.;
Disease
DISEASE: Waardenburg syndrome 4A (WS4A) [MIM:277580]: A disorder characterized by the association of Waardenburg features (depigmentation and deafness) with the absence of enteric ganglia in the distal part of the intestine (Hirschsprung disease). {ECO:0000269|PubMed:12189494, ECO:0000269|PubMed:8634719}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hirschsprung disease 2 (HSCR2) [MIM:600155]: A disorder of neural crest development characterized by absence of enteric ganglia along a variable length of the intestine. It is the most common cause of congenital intestinal obstruction. Early symptoms range from complete acute neonatal obstruction, characterized by vomiting, abdominal distention and failure to pass stool, to chronic constipation in the older child. {ECO:0000269|PubMed:11471546, ECO:0000269|PubMed:28236341, ECO:0000269|PubMed:8001158, ECO:0000269|PubMed:8630503, ECO:0000269|PubMed:8852660}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: ABCD syndrome (ABCDS) [MIM:600501]: An autosomal recessive syndrome characterized by albinism, black lock at temporal occipital region, bilateral deafness, aganglionosis of the large intestine and total absence of neurocytes and nerve fibers in the small intestine. {ECO:0000269|PubMed:11891690}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous mutations in EDNRB may be responsible for Waardenburg syndrome 2, an autosomal dominant disorder characterized by sensorineural deafness and pigmentary disturbances. {ECO:0000269|PubMed:28236341}.;
Pathway
Relaxin signaling pathway - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Melanogenesis - Homo sapiens (human);Endothelin Pathways;Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Prostaglandin Synthesis and Regulation;Signaling by GPCR;Signal Transduction;role of egf receptor transactivation by gpcrs in cardiac hypertrophy;ion channels and their functional role in vascular endothelium;activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor;chrebp regulation by carbohydrates and camp;role of -arrestins in the activation and targeting of map kinases;activation of camp-dependent protein kinase pka;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);roles of arrestin dependent recruitment of src kinases in gpcr signaling;GPCR ligand binding;-arrestins in gpcr desensitization;G alpha (q) signalling events;GPCR downstream signalling;Endothelins (Consensus)

Recessive Scores

pRec
0.729

Intolerance Scores

loftool
0.360
rvis_EVS
0.31
rvis_percentile_EVS
72.6

Haploinsufficiency Scores

pHI
0.801
hipred
Y
hipred_score
0.761
ghis
0.459

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.584

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ednrb
Phenotype
immune system phenotype; skeleton phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; neoplasm; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
ednrba
Affected structure
iridophore
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;neural crest cell migration;positive regulation of protein phosphorylation;regulation of pH;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase activity;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;nervous system development;peripheral nervous system development;posterior midgut development;aging;regulation of blood pressure;positive regulation of cell population proliferation;negative regulation of neuron maturation;response to organic cyclic compound;vein smooth muscle contraction;sensory perception of pain;calcium-mediated signaling;cGMP-mediated signaling;melanocyte differentiation;regulation of fever generation;negative regulation of cellular protein metabolic process;enteric smooth muscle cell differentiation;positive regulation of urine volume;positive regulation of renal sodium excretion;epithelial fluid transport;vasoconstriction;vasodilation;negative regulation of apoptotic process;macrophage chemotaxis;response to pain;enteric nervous system development;regulation of epithelial cell proliferation;regulation of sensory perception of pain;positive regulation of penile erection;cellular response to lipopolysaccharide;endothelin receptor signaling pathway;response to endothelin
Cellular component
plasma membrane;integral component of plasma membrane;nuclear membrane;membrane raft
Molecular function
endothelin receptor activity;protein binding;peptide hormone binding;type 1 angiotensin receptor binding